-
Gencor expands Levagen+ benefits to migraine pain relief
Published in the journalย Pharmaceuticalsโ, the research builds on past clinical trials that have demonstrated the benefits of theย palmitoylethanolamide (PEA) ingredientย across joint health, sleep, recovery, immunity, discomforts and inflammation. โIn the context of the current study on migraine pain, PEA is proposed to modulate pain by interacting with the endocannabinoid system and reducing inflammation,โ the team…
-
Gencor aims to โeven the playing fieldโ with solutions for female athletes
Presenting at the Biogredia symposium on womenโs health last week in Gstaad, Switzerland, she said that it is critical to consider theย impact of the menstrual cycle when looking at womenโs health and even more so in female athletes. โUtilisation of carbohydrates and fats can differ from day two to day 28 of a cycle, so…
-
Study explores whether Gencorโs PEA relieves allergy symptoms
Writing in the journalย Nutrients,โย researchers from the University of Queensland, Brisbaneย โnoted that standard pharmacological allergy treatments rely on the use of intranasal corticosteroids and oral antihistamines, both of which work to reduce inflammation by preventing histamine release.ย ย They suggested that PEAโa cannabimimetic compound produced in the human body and widely researched for its analgesic and anti-inflammatory…